Page last updated: 2024-12-09

4'-methoxychalcone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4'-methoxychalcone: RN given refers to compound with no isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID641818
CHEMBL ID34398
CHEBI ID174232
MeSH IDM0256215

Synonyms (61)

Synonym
CHEBI:174232
(e)-1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one
959-23-9
nsc37157
nsc-37157
2-propen-1-one, 1-(4-methoxyphenyl)-3-phenyl-
SDCCGMLS-0066535.P001
SPECTRUM5_000236
BSPBIO_002861
MEGXP0_001883
ACON1_000177
inchi=1/c16h14o2/c1-18-15-10-8-14(9-11-15)16(17)12-7-13-5-3-2-4-6-13/h2-12h,1h3/b12-7
(2e)-1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one
2-propen-1-one, 1-(4-methoxyphenyl)-3-phenyl-, (2e)-
4'-methoxychalcone
NCGC00095535-01
SPECTRUM211475
NCGC00095535-03
NCGC00095535-02
nsc 37157
LMPK12120188
(e)-1-(4-methoxy-phenyl)-3-phenyl-propenone
bdbm50141532
1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one (6)
e)-1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one
1-(4-methoxy-phenyl)-3-phenyl-propenone
CHEMBL34398 ,
AKOS001325034
STK831846
AF-961/00496034
1-(4-methoxyphenyl)-3-phenyl-2-propen-1-one
1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one
NCGC00095535-04
ST059919
bm45n45fiz ,
AB00375841-02
S5851
CCG-214164
methoxychalcone, trans-4'-
chalcone, 4'-methoxy-
4'-methoxychalcone [inci]
.alpha.-styryl p-anisyl ketone
1-(p-methoxyphenyl)-3-phenyl-2-propen-1-one
1-(4-methoxyphenyl)-3-phenylpropenone
4-methoxyphenyl styryl ketone
TS-00699
22966-19-4
styryl p-anisyl ketone
KJHHAPASNNVTSN-KPKJPENVSA-N
mfcd00008407
SR-05000002481-1
sr-05000002481
S10032
Z46053756
HY-128400
BRD-K09233738-001-04-4
Q27274750
CS-0099579
PD002123
(2e)-1-(4-methoxyphenyl)-3-phenyl-2-propen-1-one
DTXSID001238595
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
USP1 protein, partialHomo sapiens (human)Potency56.23410.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency26.10110.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency25.11890.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency17.78280.011212.4002100.0000AID1030
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency25.11890.354828.065989.1251AID504847
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency35.48130.00798.23321,122.0200AID2551
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)141.80000.03403.987110.0000AID1800143
60 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)16.00000.17004.559010.0000AID1594139
Tumor necrosis factor receptor superfamily member 1AHomo sapiens (human)IC50 (µMol)14.00007.00007.00007.0000AID226858
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)100.00000.00002.37899.7700AID1245396
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)0.47100.00001.89149.5700AID1245395
Amine oxidase [flavin-containing] BHomo sapiens (human)Ki0.02190.00061.777110.0000AID1768350
10 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)16.00000.17004.559010.0000AID1594139
Thiosulfate sulfurtransferaseHomo sapiens (human)IC50 (µMol)100.00000.06003.96319.7000AID1594135
60 kDa chaperonin Escherichia coliIC50 (µMol)21.50000.03903.55529.8000AID1594140; AID1594141
10 kDa chaperonin Escherichia coliIC50 (µMol)21.50000.03903.55529.8000AID1594140; AID1594141
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (81)

Processvia Protein(s)Taxonomy
protein folding60 kDa chaperoninEscherichia coli K-12
response to radiation60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
virion assembly60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
protein refolding60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
adhesion of symbiont to host60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell mediated immune response to tumor cell60 kDa heat shock protein, mitochondrialHomo sapiens (human)
'de novo' protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to cold60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interferon-alpha production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-10 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-12 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-6 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein refolding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell proliferation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of macrophage activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isotype switching to IgG isotypes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein stabilization60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone-mediated protein complex assembly60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein maturation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
biological process involved in interaction with symbiont60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cellular response to interleukin-760 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein import into mitochondrial intermembrane space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial unfolded protein response60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apoptotic mitochondrial changes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
aortic valve developmentTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
pulmonary valve developmentTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
negative regulation of extracellular matrix constituent secretionTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
transcription by RNA polymerase IITumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
prostaglandin metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
inflammatory responseTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
negative regulation of cardiac muscle hypertrophyTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathwayTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
cytokine-mediated signaling pathwayTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
tumor necrosis factor-mediated signaling pathwayTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of amide metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
defense response to bacteriumTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of lipid metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IITumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
negative regulation of inflammatory responseTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of inflammatory responseTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
cellular response to mechanical stimulusTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
protein localization to plasma membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of execution phase of apoptosisTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of apoptotic process involved in morphogenesisTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
regulation of establishment of endothelial barrierTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
regulation of membrane lipid metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
osteoblast differentiation10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process10 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein10 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone cofactor-dependent protein refolding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
sulfur amino acid catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
cyanate catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
epithelial cell differentiationThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA import into mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA transportThiosulfate sulfurtransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (32)

Processvia Protein(s)Taxonomy
magnesium ion binding60 kDa chaperoninEscherichia coli K-12
protein binding60 kDa chaperoninEscherichia coli K-12
ATP binding60 kDa chaperoninEscherichia coli K-12
isomerase activity60 kDa chaperoninEscherichia coli K-12
ATP hydrolysis activity60 kDa chaperoninEscherichia coli K-12
identical protein binding60 kDa chaperoninEscherichia coli K-12
unfolded protein binding60 kDa chaperoninEscherichia coli K-12
ATP-dependent protein folding chaperone60 kDa chaperoninEscherichia coli K-12
lipopolysaccharide binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
p53 binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
DNA replication origin binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
single-stranded DNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
double-stranded RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
high-density lipoprotein particle binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isomerase activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP hydrolysis activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
enzyme binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ubiquitin protein ligase binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein A-I binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP-dependent protein folding chaperone60 kDa heat shock protein, mitochondrialHomo sapiens (human)
tumor necrosis factor receptor activityTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
protein bindingTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
tumor necrosis factor bindingTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
RNA binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding chaperone10 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
metal ion binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
thiosulfate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
5S rRNA bindingThiosulfate sulfurtransferaseHomo sapiens (human)
3-mercaptopyruvate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (29)

Processvia Protein(s)Taxonomy
cytoplasm60 kDa chaperoninEscherichia coli K-12
cytosol60 kDa chaperoninEscherichia coli K-12
membrane60 kDa chaperoninEscherichia coli K-12
GroEL-GroES complex60 kDa chaperoninEscherichia coli K-12
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytoplasm60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrion60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
early endosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytosol60 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
clathrin-coated pit60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cell surface60 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
coated vesicle60 kDa heat shock protein, mitochondrialHomo sapiens (human)
secretory granule60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm midpiece60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
migrasome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-containing complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
lipopolysaccharide receptor complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
Golgi membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
extracellular regionTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
extracellular spaceTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
plasma membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
cell surfaceTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
membrane raftTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
tumor necrosis factor receptor superfamily complexTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
receptor complexTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
membrane raftTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrion10 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane10 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome10 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix10 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular spaceThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrial matrixThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (68)

Assay IDTitleYearJournalArticle
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1105384Antibacterial activity against Erwinia chrysanthemi ITCC B-40 assessed as as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1768347Antiproliferative activity against human MSTO-211H cells assessed as cell growth inhibition measured after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1896715Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1768346Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1768349Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI cells assessed as inhibition of H2O2 production using kynuramine as substrate preincubated for 5 mins followed by substrate addition by Amplex Red reagent based fluorescence analy2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1488990Antiproliferative activity against human HCT116 cells assessed as growth inhibition after 3 days by SRB assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID1543107Selectivity index, ratio of CC50 for cytotoxicity in mouse NCTC-929 cells to EC50 for Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes infected in LLC-MK2-ATCC CCL7 cells2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
AID1896709Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1594143Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reducti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1244252Antiinvasive activity in human MCF7/6 cells assessed as Cmin for progressive occupation of chicken precultured heart tissue fragments after 8 days by chick heart invasion assay2015European journal of medicinal chemistry, Aug-28, Volume: 1014-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model.
AID1896710Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dRho refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1594141Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1105408Antibacterial activity against Bacillus thuringiensis MTCC 6941 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID606521Induction of Nrf2-mediated GCLM gene expression in human BEAS2B cells at 10 uM after 16 hrs by RT-PCR analysis relative to untreated control2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.
AID450074Antimicrobial activity against Staphylococcus aureus ATCC 29213 up to 100 ug/mL by broth microdilution assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
AID1105386Antifungal activity against Athelia rolfsii ITCC 6181 by food poisoning method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1488988Antiproliferative activity against human HCT116 cells at 25 uM after 3 days by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID1896714Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID450077Antigiardial activity against Giardia lamblia WB (ATCC 30957) trophozoites assessed as mild activity after 24 hrs by trypan blue assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
AID1543105Antitrypanosomal activity against Trypanosoma cruzi Y trypomastigotes infected in LLC-MK2-ATCC CCL7 cells assessed as reduction in parasite growth incubated for 24 hrs by Alamar blue dye based assay2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
AID1594140Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1594137Inhibition of ATPase activity of Escherichia coli GroEL expressed in Escherichia coliDH5alpha incubated for 60 mins using ATP by spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1768351Selectivity index, ratio of inhibition of recombinant human MAO-A to inhibition of recombinant human MAO-B2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1896713Inhibition of refolded MDH reporter enzyme (unknown origin)2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1768345Antiproliferative activity against human A2780 cells assessed as cell growth inhibition measured after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1594142Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduct2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID450075Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 up to 100 ug/mL by broth microdilution assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
AID1105385Antifungal activity against Rhizoctonia solani ITCC 5563 by food poisoning method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1896716Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1105381Antibacterial activity against Xanthomonas oryzae ITCC B-47 assessed as as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID450073Antimicrobial activity against Enterococcus faecalis ATCC 29212 up to 100 ug/mL by broth microdilution assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
AID1896719Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1896712Inhibition of refolded rhodanese reporter enzyme (unknown origin)2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1896717Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1768350Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI cells assessed as inhibition of H2O2 production using kynuramine as substrate preincubated for 5 mins followed by substrate addition by Amplex Red reagent based fluorescence analy2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1594138Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction i2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1105405Antibacterial activity against Staphylococcus aureus MTCC 3160 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1105397Antioxidant activity assessed as DPPH free radical scavenging activity after 20 min by UV-Vis spectrophotometric analysis2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1896711Inhibition of human mitochondrial HSP60 expressed in Escherichia coli Rosetta 2 (DE3) cells/human mitochondrial HSP10 expressed in Escherichia coli Rosetta 2 (DE3) pLysS cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1245395Inhibition of recombinant human MAOB using benzylamine as substrate after 30 mins by Amplex red based spectrophotometric analysis2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
AID1896718Cytotoxicity against human FHs74Int cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1105407Antibacterial activity against Bacillus pumilus MTCC 2466 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1245397Selectivity index, ratio of IC50 for recombinant human MAOA to IC50 for recombinant human MAOB2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
AID1594139Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID450076Antimicrobial activity against Escherichia coli ATCC 25922 up to 100 ug/mL by broth microdilution assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
AID1105406Antibacterial activity against Klebsiella pneumoniae MTCC 7028 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1245396Inhibition of recombinant human MAOA using p-tyramine as substrate after 30 mins by Amplex red based spectrophotometric analysis2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
AID226858Inhibition of TNF-alpha-induced VCAM-1 expression2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.
AID89025Inhibition of the production of Interleukin-1-beta from human peripheral blood monocytes stimulated with lipopolysaccharide (LPS) at 10 uM1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis.
AID1488989Antiproliferative activity against human HCT116 cells at 50 uM after 3 days by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID1594136Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1105404Antibacterial activity against Pseudomonas aeruginosa MTCC 2581 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1896720Selectivity index, ratio of CC50 for cytotoxicity against non-cancerous cells to EC50 for cytotoxicity against human HCT-116 cells2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID16448Calculated partition coefficient (clogP)2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.
AID1543106Cytotoxicity in mouse NCTC-929 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
AID655021Antagonist activity at androgen receptor in human LNCAP cells assessed as decrease in prostate specific antigen mRNA level at 2.5 uM after 20 hrs by real time RT-PCR analysis relative to control2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Methoxychalcone inhibitors of androgen receptor translocation and function.
AID1594134Inhibition of native soluble pig heart MDH assessed as reduction in MDH enzyme activity using sodium mesoxalate as substrate and NADH by malachite green dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID606613Induction of Nrf2-mediated NQO1 gene expression in human BEAS2B cells at 10 uM after 16 hrs by RT-PCR analysis relative to untreated control2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.
AID1488991Antiproliferative activity against human CAL51 cells assessed as growth inhibition after 3 days by SRB assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID1594135Inhibition of native rhodanese (unknown origin) assessed as reduction in rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1768352Cytotoxicity against human MET5A cells assessed as cell growth inhibition after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1800143Spectrophotometric Assay from Article 10.1111/cbdd.12126: \\Microwave-assisted synthesis and tyrosinase inhibitory activity of chalcone derivatives.\\2013Chemical biology & drug design, Jul, Volume: 82, Issue:1
Microwave-assisted synthesis and tyrosinase inhibitory activity of chalcone derivatives.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (8.00)18.2507
2000's3 (12.00)29.6817
2010's16 (64.00)24.3611
2020's4 (16.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.72 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index46.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]